Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular disease.
暂无分享,去创建一个
M. Woodward | S. MacMahon | N. Sharpe | J. Chalmers | B. Neal | Anushka Patel | J. Reid | L. Hansson | G. Mancia | V. Chaturvedi
[1] J. Bosch,et al. Use of ramipril in preventing stroke: double blind randomised trial , 2002, BMJ : British Medical Journal.
[2] M. Davidsen,et al. Long-Term Survival and Causes of Death After Stroke , 2001, Stroke.
[3] Duolao Wang,et al. Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure , 2001, European journal of heart failure.
[4] B Neal,et al. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials , 2000, The Lancet.
[5] Salim Yusuf,et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients , 2000, The Lancet.
[6] E. Feskens,et al. The Relation between Blood Pressure and Mortality Due to Coronary Heart Disease among Men in Different Parts of the World , 2000 .
[7] M. Moser,et al. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. , 1996, Journal of the American College of Cardiology.
[8] Michael A. Proschan,et al. Rationale and Design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) , 1996 .
[9] J. Cutler,et al. Blood Pressure and Mortality Among Men With Prior Myocardial Infarction , 1995 .
[10] S. Yusuf,et al. Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure , 1995 .
[11] S. Yusuf,et al. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. , 1994, Circulation.
[12] B. Pitt,et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions , 1992, The Lancet.
[13] R. Collins,et al. Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.
[14] R. Collins,et al. Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias , 1990, The Lancet.
[15] R. Peto,et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.
[16] M. Nieminen,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .